Universita degli Studi di Genova
Quick facts
Marketed products
- Amoxicillin Long
- Amoxicillin Short · Infectious Disease
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Universita degli Studi di Genova portfolio CI brief
- Universita degli Studi di Genova pipeline updates RSS
Frequently asked questions about Universita degli Studi di Genova
What are Universita degli Studi di Genova's marketed drugs?
Top marketed products include Amoxicillin Long, Amoxicillin Short.
Related
- Amoxicillin Long
- Amoxicillin Short · Infectious Disease
- Sector hub: All tracked pharma companies